Isocitrate dehydrogenase (IDH) mutation, 1p/19q codeletion status, and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation have all been well demonstrated to relate with the malignancy of gliomas. This evidence concerns the gene IDH3A and glioma.